Abstract
Results of the Phase 3 Study of Lenalidomide Versus Placebo As Maintenance Therapy Following Second-Line Treatment for Patients with Chronic Lymphocytic Leukemia (the CONTINUUM Trial)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have